EGFR-IN-8
目录号: PL02815 纯度: ≥98%
CAS No. :2407957-87-1
商品编号 规格 价格 会员价 是否有货 数量
PL02815-5mg 5mg ¥4327.27 请登录
PL02815-10mg 10mg ¥7170.91 请登录
PL02815-50mg 50mg ¥20400.00 请登录
PL02815-100mg 100mg ¥31527.27 请登录
PL02815-200mg 200mg 询价 询价
PL02815-500mg 500mg 询价 询价
PL02815-10mM*1mLinDMSO 10mM*1mLinDMSO ¥6305.45 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
EGFR-IN-8
英文名称
EGFR-IN-8
英文别名
EGFR-IN-8;N-(3-Chloro-4-(5-(3-(3-(4-(cyclopropanecarboxamido)-3-(trifluoromethyl)phenyl)ureido)phenyl)-1,2,4-oxadiazol-3-yl)phenyl)nicotinamide
Cas No.
2407957-87-1
分子式
C32H23ClF3N7O4
分子量
662.02
包装储存
Powder -20°C 3 years;4°C 2 years
产品详情
EGFR-IN-8 是 EGFR 和 c-Met 双重抑制剂,化合物 48。EGFR-IN-8 有望成为进一步开发靶向 EGFR TKI 抗性 NSCLC 药物的靶点。
生物活性
EGFR-IN-8 is a dual EGFR and c-Met inhibitor, compound 48. EGFR-IN-8 can be a promising candidate for further development to target EGFR TKI-resistant NSCLC.
性状
Solid
IC50 & Target[1][2]
EGFR; c-Met
体外研究(In Vitro)
EGFR-IN-8 (0-20 μM; 24-72 hours) exhibits a time- and dose-dependent inhibitory effect on the viability of A549, PC9, H1975, CL68, and CL97?cells at different time intervals, with IC50 values ranging from 0.3 to 0.6?μM and 0.2-0.5?μM after 48 and 72?h of treatment respectively.
EGFR-IN-8 (0-0.6 μM; 48 hours) suppresses the expression of EGFR and c-Met in these five cell lines irrespective of their mutational status.
has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
EGFR-IN-8 (oral gavage; 50 and 150?mg/kg; once daily; 20 days) exhibits a dose-dependent suppression (29% and 60%, respectively) of H1975 xenograft tumor growth at 50 and 150?mg/kg.
has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model:
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Dokla EME, et al. 1,2,4-Oxadiazole derivatives targeting EGFR and c-Met degradation in TKI resistant NSCLC. Eur J Med Chem. 2019 Aug 9;182:111607.
溶解度数据
In Vitro: DMSO : 8.33 mg/mL (12.58 mM; Need ultrasonic)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2